CBIO
CRESCENT BIOPHAR (CBIO)
NASDAQ
$16.71-$0.44 (-2.55%)
Price as of Aug 21, 2026 7:56 PM EDT
  • $292.5M
    Market Cap
  • 13.88%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
10.8M
+108,340.00%
10,000
0.00%
10,000
-86.67%
75,000
-93.53%
Cost of Revenue
19.9M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-9.1M
-90,920.00%
10,000
0.00%
10,000
-86.67%
75,000
-93.53%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-138.1M
+868.36%
-14.3M
-28.96%
-20.1M
-29.30%
-28.4M
-40.22%
Depreciation and Amortization Expense
84,000
+138.81%
35,174
-77.06%
153,301
-25.99%
207,145
-21.71%
Total Operating Expenses
163.5M
+308.29%
40.0M
+1.92%
39.3M
-17.26%
47.5M
-26.51%
Operating Profit
-152.6M
+281.20%
-40.0M
+1.95%
-39.3M
-17.15%
-47.4M
-25.29%
Interest Income
2.9M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-2.2M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
690,000
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-690,000
-131.94%
2.2M
-9.08%
2.4M
+232.51%
714,520
+3,514.53%
Income before Taxes
-151.9M
+279.48%
-40.0M
+1.95%
-39.3M
-17.15%
-47.4M
-25.29%
Income Taxes
2.0M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-153.9M
+306.40%
-37.9M
+2.66%
-36.9M
-20.97%
-46.7M
-26.39%
Net Income from Continuing Operations Applicable to Common
-151.9M
+301.12%
-37.9M
+2.66%
-36.9M
-20.97%
-46.7M
-26.39%
Basic EPS and Net Income
N/A
N/A
-0.59
+1.72%
-0.58
-34.83%
-0.89
-27.64%
Diluted EPS and Net Income
N/A
N/A
-0.59
+1.72%
-0.58
-34.83%
-0.89
-27.64%
Basic Weighted Average Shares
N/A
N/A
64.5M
+1.79%
63.3M
+20.58%
52.5M
+2.10%
Diluted Weighted Average Shares
N/A
N/A
64.5M
+1.79%
63.3M
+20.58%
52.5M
+2.10%
Balance Sheet
Cash and Cash Equivalents
213.2M
+1,888.70%
10.7M
-74.35%
41.8M
-12.70%
47.9M
-46.96%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
213.2M
+1,888.70%
10.7M
-74.35%
41.8M
-12.70%
47.9M
-46.96%
Total Current Assets
236.7M
+2,033.67%
11.1M
-74.67%
43.8M
-13.65%
50.7M
-44.14%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
2.4M
+2.74%
Property and Plant and Equipment and Net
846,000
N/A
N/A
N/A
N/A
N/A
242,390
-34.28%
Total Long-Term Assets
1.2M
+688.71%
154,176
0.00%
154,176
-36.39%
242,390
-34.28%
Total Assets
240.3M
+2,066.47%
11.1M
-75.52%
45.3M
-12.53%
51.8M
-45.08%
Income Taxes Payable
8.0M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
36.1M
+524.31%
5.8M
-15.47%
6.8M
-23.03%
8.9M
-24.89%
Total Long-Term Debt
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1.2M
+1,708.69%
66,844
0.00%
66,844
-92.72%
918,607
0.00%
Total Liabilities
37.3M
+545.24%
5.8M
-16.29%
6.9M
-22.28%
8.9M
-30.31%
Retained Earnings
-171.8M
-65.25%
-494.4M
+8.30%
-456.5M
+8.79%
-419.6M
+12.52%
Total Stockholders Equity
203.0M
+3,720.64%
5.3M
-86.17%
38.4M
-10.52%
42.9M
-47.39%
Total Shares Outstanding
27.6M
-57.27%
64.5M
+0.14%
64.4M
+18.42%
54.4M
+3.95%
Cash Flow
Cash from Operating Activities
-71.5M
+130.02%
-31.1M
-10.84%
-34.9M
-24.92%
-46.5M
-19.19%
Capital Expenditures
919,000
+9,115.80%
9,972
-53.39%
21,394
-74.59%
84,191
+463.41%
Cash from Investing Activities
-72.9M
-364,185.28%
20,028
+193.62%
-21,394
-74.59%
-84,191
+463.41%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
323.0M
+5,983,301.26%
5,398
-99.98%
28.8M
+593.30%
4.2M
-61.23%
Financials Ratio
Gross Margin
-83.75%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,407.52%
-99.65%
-400,393.78%
+1.95%
-392,752.93%
+521.40%
-63,204.43%
+1,055.33%
Return on Assets
-122.48%
-8.81%
-134.30%
+76.76%
-75.98%
+18.93%
-63.89%
+19.45%
Return on Equity
-147.79%
-14.70%
-173.25%
+90.96%
-90.72%
+20.99%
-74.98%
+24.02%
Revenue Growth
108,340.00%
N/A
0.00%
+100.00%
-86.67%
-7.34%
-93.53%
+5.58%
Current Ratio
6.56
+241.77%
1.92
-70.04%
6.41
+12.19%
5.71
-25.62%
Cash Ratio
5.91
+218.54%
1.86
-69.65%
6.11
+13.43%
5.39
-29.38%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow